Political anxiety has become a dominant theme in our culture. We present some of the prominent features and suggestions about ...

Mental health professionals reveal the hidden signs of anxiety disorders affecting millions of Americans, from mysterious ...

You're probably familiar with the symptoms of anxiety: feeling worried, racing thoughts, and being irritable. But while being ...

A new Cochrane review showed SSRIs and SNRIs outperform placebo for GAD with similar dropout rates, but questions remain ...

Lexapro is an antidepressant medication commonly prescribed for anxiety. Here's how to know the best time of day to take it.

A Boston VC firm is launching a new neuroscience company with a $93M investment that aims to treat disorders including ...

Calming exercises can help tame anxiety, but a creative life is a cure-all according to author Martha Beck: “Anxiety can’t ...

H.C. Wainwright analyst Pat Trucchio adjusted the price target for Cybin Inc. (NYSE:CYBN) stock, lowering it to $150.00 from the previous $190.00 while maintaining a Buy rating on the company.

Shares in Mind Medicine (MNMD) are surging, following a shift in market sentiment regarding possible growth and the potential ...

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and a plan to develop drugs for brain function and health.

Canaccord analyst Sumant Kulkarni lowered the firm’s price target on Cybin (CYBN) to $73 from $86 and keeps a Buy rating on the shares. The ...